Zydus Cadila Launches a Research Program to Develop Vaccine Against Coronavirus

 Zydus Cadila Launches a Research Program to Develop Vaccine Against Coronavirus

Zydus Cadila Launches a Research Program to Develop Vaccine Against Coronavirus

Shots:

  • Zydus has initiated an accelerated research program with multiple teams in India and the EU to develop a vaccine against coronavirus, 2019-nCoV (COVID-19) based on two approaches
  • The two approaches include the development of DNA vaccine by Zydus’ VTC and a live attenuated recombinant measles virus vectored vaccine by Zydus’ Etna Biotech to combat COVID
  • Zydus’ manufacturing facilities for producing recombinant antigens and measles-containing vaccines will enable rapid ramping up of the production for both vaccine candidates, once the proof-of-concept is established

Click here ­to­ read full press release/ article | Ref: Zydus Cadila  | Image:  Zydus Cadila

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post